Thats the heart of the question many of us bring to the clinic: your goals, medical history, and tolerance for side effects matter
This greater weight loss potential may confer additional OSA benefits for patients who begin treatment with moderate to severe sleep apnea
In NRF2 active cells, this reaction produces toxic and wasteful metabolites, consequently leading to the epigenetic silencing of CDO1 in human non-small cell lung cancer to alleviate this detrimental metabolism
Participants were randomized in a 1:1 ratio to receive Mazdutide 6 mg or Semaglutide 1 mg for 32 weeks, & in the extension period, participants originally on Mazdutide were assigned to continue Mazdutide treatment at different doses for another 24 weeks, based on whether they achieved the weight-loss target
Be sure to consult with your healthcare provider before restarting treatment, as dosage adjustments may be necessary
Soudah, T., Mogilevsky, M., Karni, R